Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, M.
Right arrow Articles by Rajkumar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, M.
Right arrow Articles by Rajkumar, S.
Haematologica, Vol 89, Issue 5, 626-628
Copyright © 2004 by Ferrata Storti Foundation

Letter

Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control study

MA Thompson, RA Kyle, LJ Melton 3rd, MF Plevak, and SV Rajkumar

Interleukin-6 (IL-6) and C-reactive protein (CRP, a surrogate marker for IL-6) are important in monoclonal gammopathy of undetermined significance (MGUS) and myeloma. Smoking and obesity may elevate CRP levels, while statins decrease CRP levels. A case-control study in 200 MGUS patients found that statin use, smoking history and obesity do not affect MGUS progression.


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
B. M. Birmann, E. Giovannucci, B. Rosner, K. C. Anderson, and G. A. Colditz
Body Mass Index, Physical Activity, and Risk of Multiple Myeloma
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1474 - 1478.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2004 by the Ferrata Storti Foundation.